Stigma Reduction Intervention for MSM and Healthcare Providers
Adapting an Intervention to Reduce Stigma Among MSM and Healthcare Providers in Vietnam
This study describes only the Aim 2 clinical trial component of the NIH-funded project "Adapting an Intervention to Reduce Stigma among MSM and Healthcare Providers in Vietnam". The purpose of this pilot randomized waitlist-controlled trial (N=180) is to evaluate the preliminary efficacy of DONGHANH, a stigma-reduction intervention for men who have sex with men and healthcare providers in Vietnam. The study will provide preliminary data on the intervention's potential impact to inform the design of a larger future trial evaluating its effects on HIV prevention and care outcomes in Vietnam and in other countries with collectivist cultures.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
This is a pilot randomized waitlist-controlled trial of DONGHANH, a stigma-reduction intervention for men who have sex with men (MSM) and healthcare providers (HCP) in Vietnam. Participants are randomized 1:1 to receive DONGHANH immediately or to a waitlist control. Waitlist participants receive the same DONGHANH workshops after the 3-month assessment. Assessments occur at baseline and 3 months for all participants. Participants in the immediate intervention arm complete an additional assessment at 6 months. Efficacy outcomes are analyzed using generalized linear mixed models or generalized estimating equations, with the intervention-by-time interaction as the primary test of effect.
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Toan Ha, MD, DrPH
- Telefonnummer: 412-383-4576
- E-mail: toh33@pitt.edu
Studiesteder
-
-
-
Hanoi, Vietnam
- Institute of Social and Medical Studies
-
Kontakt:
- Nam T Nguyen, MD, DrPH
- Telefonnummer: +84-02435558288
- E-mail: ntnam@isms.org.vn
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
MSM:
- Age 18 years or older
- Cisgender male
- HIV-positive, HIV-negative, or unknown HIV status
- Self-reported history of condomless sex
- Able to provide written informed consent
Healthcare providers:
- Age 18 years or older
- Works in an HIV outpatient clinic or community-based organization clinic in Hanoi
- Able to provide informed consent
Exclusion Criteria:
- Unable to provide informed consent
- Unable to read and understand Vietnamese
- Currently enrolled in another HIV intervention study.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: DONGHANH Intervention
DONGHANH is a stigma-reduction intervention for men who have sex with men (MSM) and healthcare provider (HCP) in Vietnam. The intervention is delivered through five workshops attended jointly by MSM and HCP participants. Each workshop lasts approximately 1.5 days and consists of 10 modules. The modules use presentations, group discussions, and interactive exercises to build understanding of HIV-related and sexuality-related stigma; facilitate the sharing of personal experiences of stigma among MSM and HCP participants; explore the health effects of stigma; and develop strengths and strategies for coping with and reducing stigma. |
DONGHANH is a culturally adapted, group-based patient-provider stigma-reduction workshop for men who have sex with men (MSM) and healthcare providers (HCP) in Hanoi. The workshop brings together MSM and HCP for about 1.5 days across 10 modules covering understanding stigma, intersecting stigmas and their outcomes, HIV knowledge, coping with and changing stigma, and developing stigma-reduction tools. It is led by 3 trained facilitators (1 MSM, 1 HCP, 1 co-facilitator) and uses presentations, exercises, small-group work, and group presentations. Participants also contribute suggestions to contents of a supplementary e-module (website) conveying information about stigma and stigma reduction strategies. |
|
Eksperimentel: Waitlist control group
Participants in this arm receive no intervention for the first 3 months after randomization. During this period, study staff contact them every 2 weeks to maintain retention. These contacts do not include any intervention content. After the 3-month assessment, participants receive the same DONGHANH workshops Assessments occur at baseline, 3 months and 6 months |
DONGHANH is a culturally adapted, group-based patient-provider stigma-reduction workshop for men who have sex with men (MSM) and healthcare providers (HCP) in Hanoi. The workshop brings together MSM and HCP for about 1.5 days across 10 modules covering understanding stigma, intersecting stigmas and their outcomes, HIV knowledge, coping with and changing stigma, and developing stigma-reduction tools. It is led by 3 trained facilitators (1 MSM, 1 HCP, 1 co-facilitator) and uses presentations, exercises, small-group work, and group presentations. Participants also contribute suggestions to contents of a supplementary e-module (website) conveying information about stigma and stigma reduction strategies. |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Feasibility of the intervention
Tidsramme: 3 months
|
Feasibility of the intervention will be assessed with the feasibility of intervention measure, a 4-item scale. Each item is rated from 1 (completely disagree) to 5 (completely agree). The score is the mean of the four items, with a minimum of 1 and a maximum of 5. Higher scores indicate greater perceived feasibility. Results will be reported separately for among MSM and healthcare providers. |
3 months
|
|
Acceptability of of the intervention
Tidsramme: 3 months
|
Acceptability of the intervention will be assessed with the acceptability of intervention measure, a 4-item scale. Each item is rated from 1 (completely disagree) to 5 (completely agree). The score is the mean of the four items, with a minimum of 1 and a maximum of 5. Higher scores indicate greater acceptability. Results will be reported separately for MSM and healthcare providers. |
3 months
|
|
Appropriateness of the intervention
Tidsramme: 3 months
|
Appropriateness of the intervention will be assessed using the intervention appropriateness measure, a 4-item scale. Each item is rated from 1 (completely disagree) to 5 (completely agree). The overall score is calculated as the mean of the four items, ranging from 1 to 5. Higher scores indicate greater perceived appropriateness. Results will be reported separately for MSM and healthcare providers. |
3 months
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Changes in stigma
Tidsramme: Baseline, 3 months, and 6 months
|
Change in stigma will be measured using the homosexuality-related stigma scale (Vietnamese version), a self-report measure of stigma among MSM. The scale has three subscales: enacted stigma (7 items, rated 1 [never] to 4 [many times]), perceived stigma (11 items), and internalized stigma (8 items). Perceived and internalized stigma items are rated 1 (strongly disagree) to 4 (strongly agree). Each subscale score is the mean of its items and ranges from 1 to 4. Higher scores indicate greater stigma. Change is calculated as the 3-month and 6- month score minus the baseline score. |
Baseline, 3 months, and 6 months
|
|
Change in observed HIV-related stigma in healthcare settings
Tidsramme: Baseline, 3 months, and 6 months
|
Change in observed HIV-related stigma will be measured using 3 items assessing HIV-related stigma among health facility staff. Items ask how often participants observed stigmatizing behaviors in their health facility in the past 12 months (for example, health workers unwilling to care for a patient living with HIV). Each item is rated on a 4-point frequency scale: 1 (never), 2 (once or twice), 3 (several times), and 4 (most of the time). The score is the sum of the 3 items and ranges from 3 to 12. Higher scores indicate more observed stigma. |
Baseline, 3 months, and 6 months
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Samarbejdspartnere
Samarbejdspartnere
Efterforskere
Efterforskere
- Ledende efterforsker: Toan Ha, MD, DrPH, University of Pittsburgh
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- STUDY26010095
- R01TW013193 (U.S. NIH-bevilling/kontrakt)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
De-identified individual participant data (IPD) underlying the results reported in publications will be deposited in an NIH-supported repository for HIV-related behavioral research. Access will be controlled and subject to a data use agreement prohibiting re-identification and unauthorized disclosure. Given the sensitive nature of HIV-related information and sexual orientation, and the risk of re-identification in small samples, data will be reviewed and de-identified before sharing. Data will be made available in accordance with repository policies and applicable consent, ethical, and institutional requirements, for as long as the repository maintains the data and makes them available.
IPD-delingstidsramme
Data underlying published results will be available upon publication. Any other Aim 2 data will be shared by the end of the award period at the latest. Data will remain available in the repository for a minimum of 7 years.
IPD-delingsadgangskriterier
Data will be available free of charge through the Mendeley Data repository. Users must register with the repository and agree to its terms, which restrict use to scientific research and aggregate statistical reporting. Data will be findable through a digital object identifier assigned by the repository. Access will follow the informed consent and institutional requirements, and any data designated as restricted use will be available under the repository's restricted-access terms.
IPD-deling Understøttende informationstype
- SAP
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .